VANCOUVER, BC — Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic drug development company, today announced that it intends to complete, subject to regulatory… Read More
OTTAWA, ON — The annual BIOTECanada Gold Leaf Awards ceremony was held this week at the National Arts Centre in Ottawa. The awards recognize the remarkable individuals and companies who… Read More
RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, will release its third quarter 2023… Read More
Completed Phase 2 Clinical Trial demonstrating anti-itch activity of INM-755 (CBN) topical cream $4.1M revenues in fiscal year 2023, representing a 280% increase over the previous fiscal year and $2.3M… Read More
HIGHLIGHTS • Advancements in genetic and genomic technologies allow for more customized health care called ‘precision health’. • For precision health technologies to be effective, health care providers and educators… Read More
